Recent Advances in Antiarrhythmic Drug Therapy

Cardiac arrhythmias remain a common cause of death and disability. Antiarrhythmic drugs (AADs) and antiarrhythmic agents remain a cornerstone of current cardiac arrhythmia management, despite moderate efficacy and the potential for significant adverse proarrhythmic effects. Due to conceptual, regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Saljic, Arnela, Heijman, Jordi, Dobrev, Dobromir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462572/
https://www.ncbi.nlm.nih.gov/pubmed/37540446
http://dx.doi.org/10.1007/s40265-023-01923-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462572/
https://www.ncbi.nlm.nih.gov/pubmed/37540446
http://dx.doi.org/10.1007/s40265-023-01923-3

Ejemplares similares